Evolus, Inc. current report, 03 March 2022

Evolus, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Evolus, Inc. on March 4, 2022, covering events occurring on March 3, 2022. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq Global Market under the symbol EOLS.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and personnel changes.

Material Changes

The primary material event reported is the announced retirement of Lauren Silvernail, the Company's Chief Financial Officer and Executive Vice President, Corporate Development. Her retirement is effective May 31, 2022, for personal reasons. The Company states there are no disagreements regarding operations, policies, or accounting practices. A search for a successor is currently underway.

Outlook, Risks, and Unusual Items

Compensatory Arrangements: A Separation Agreement dated March 3, 2022, outlines the following terms for Ms. Silvernail upon her retirement date, subject to a release of claims:

  • A lump sum payment equal to 9 months of base salary.
  • A lump sum payment representing her pro-rated 2022 bonus potential.
  • Company-paid COBRA premiums for health insurance through September 30, 2023.
  • Reimbursement of business expenses in accordance with company policy.
  • Accelerated vesting of one additional year for certain equity awards.

Regulatory Disclosure: The Company issued a press release regarding this departure, which is included as Exhibit 99.1. The filing notes that the separation agreement will be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending March 31, 2022.

Key Facts for Investor Verification

  • Verify the timeline for the appointment of a new Chief Financial Officer.
  • Review the full Separation Agreement in the upcoming Form 10-Q for detailed restrictive covenants and release terms.
  • Monitor subsequent filings for any impact on the Company's financial reporting or internal controls during the transition period.